Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1049 | 1011 | 1051 | 1039 | 1297 | 2276 |
Fund Return | 4.87% | 1.14% | 5.05% | 1.3% | 5.34% | 8.57% |
Place in category | 644 | 278 | 566 | 410 | 351 | 162 |
% in Category | 62 | 29 | 64 | 64 | 80 | 61 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -4.38 | - | ||
FIM Emerging markets ESG | 376.23M | -1.19 | -2.57 | 4.27 | ||
S SaastOrahasto Kohtuullinen | 286.82M | 5.82 | 3.59 | 5.88 | ||
S-Saastorahasto Rohkea | 251.52M | 8.56 | 6.47 | 8.40 | ||
FIM USA | 234.4M | 15.22 | 12.38 | 12.82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife K | 93.85M | 9.65 | 9.07 | 11.85 | ||
Danske Invest MediLife T | 576.99K | 9.65 | 9.08 | 11.85 | ||
Seligson Global Top 25 Pharmac B | 268.79M | 6.08 | 11.04 | 8.93 | ||
Seligson Co Global Top 25 Pharma A | 268.79M | 6.08 | 11.03 | 8.91 | ||
LahiTapiola Hyvinvointi A | 140.47M | 4.87 | 1.29 | 8.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.45 | 905.38 | -0.40% | |
Novo Nordisk B | DK0062498333 | 6.37 | 1,005.6 | +0.30% | |
Vertex | US92532F1003 | 3.58 | 468.72 | -0.80% | |
Amgen | US0311621009 | 3.41 | 312.45 | -0.40% | |
AstraZeneca | GB0009895292 | 3.25 | 12,356.0 | +0.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review